<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32638110</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>267</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Disease progression but not physical state per se determines mental wellbeing in ALS.</ArticleTitle><Pagination><StartPage>3593</StartPage><EndPage>3601</EndPage><MedlinePgn>3593-3601</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-020-10027-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studies provide inconclusive results on the question whether loss of mental wellbeing is actually associated with decline in physical function in amyotrophic lateral sclerosis (ALS). The purpose of this study was to determine predictors of mental wellbeing in ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In total, n&#x2009;=&#x2009;330 ALS patients were interviewed on parameters of mental wellbeing to evaluate the patients' capacity of psychosocial adaptation. These parameters were global and subjective quality of life (QoL), and depressiveness. A subsample of n&#x2009;=&#x2009;82 ALS patients were interviewed again within approximately a year (mean 14.34&#x2009;&#xb1;&#x2009;5.53&#xa0;months).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both global and subjective QoL were stable, whereas depressiveness increased within the course of 1 year after diagnosis. Physical function decline was associated with mental wellbeing. Progression of physical disabilities and symptom duration were significant predictors of wellbeing in the sense that fast progression and short time since symptom onset (both indicating short time to adapt) were associated with low wellbeing.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is evidence for subsamples in ALS with regard to mental wellbeing, which are mainly determined by clinical parameters. Those subjects being reported in the literature to present with high mental wellbeing are often long survivors. High progression rate and low physical function when attending the clinic for the first time should be red flags and need special attention in clinical counseling.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>V&#xe1;zquez Medrano</LastName><ForeName>Cynthia R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aho-&#xd6;zhan</LastName><ForeName>Helena E A</ForeName><Initials>HEA</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiland</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uttner</LastName><ForeName>Ingo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lul&#xe9;</LastName><ForeName>Doroth&#xe9;e</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5944-398X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany. dorothee.lule@uni-ulm.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>01ED1405</GrantID><Agency>EU Joint Programme - Neurodegenerative Disease Research (NEEDSinALS)</Agency><Country/></Grant><Grant><GrantID>01ED1512</GrantID><Agency>EU Joint Programme - Neurodegenerative Disease Research (PreFrontAls)</Agency><Country/></Grant><Grant><GrantID>DFG, LU 336/13-2</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>FTLDc O1Gl1007A</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant><Grant><GrantID>MND-Net01GM1103A</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant><Grant><GrantID>PaCeMed 01DS18031</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006233" MajorTopicYN="Y">Disabled Persons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Depressiveness</Keyword><Keyword MajorTopicYN="N">Physical function</Keyword><Keyword MajorTopicYN="N">Progression rate</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Wellbeing</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32638110</ArticleId><ArticleId IdType="pmc">PMC7674363</ArticleId><ArticleId IdType="doi">10.1007/s00415-020-10027-x</ArticleId><ArticleId IdType="pii">10.1007/s00415-020-10027-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC. Amyotrophic lateral sclerosis and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2012;83(4):355. doi: 10.1136/jnnp-2012-302357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302357</ArticleId><ArticleId IdType="pubmed">22399791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Ehlich B, Lang D, Sorg S, Heimrath J, K&#xfc;bler A, Birbaumer N, Ludolph AC. Quality of life in fatal disease: the flawed judgement of the social environment. J Neurol. 2013;260(11):2836&#x2013;2843. doi: 10.1007/s00415-013-7068-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7068-y</ArticleId><ArticleId IdType="pubmed">23989341</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55(3):388&#x2013;392. doi: 10.1212/wnl.55.3.388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.55.3.388</ArticleId><ArticleId IdType="pubmed">10932273</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;bler A, Winter S, Ludolph AC, Hautzinger M, Birbaumer N. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair. 2005;19(3):182&#x2013;193. doi: 10.1177/1545968305276583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968305276583</ArticleId><ArticleId IdType="pubmed">16093409</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamshiri H, Fatehi F, Abolfazli R, Harirchian MH, Sedighi B, Zamani B, Roudbari A, Razazian N, Khamseh F, Nafissi S. Trends of quality of life changes in amyotrophic lateral sclerosis patients. J Neurol Sci. 2016;368:35&#x2013;40. doi: 10.1016/j.jns.2016.06.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.056</ArticleId><ArticleId IdType="pubmed">27538598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillemacher T, Gr&#xe4;ssel E, Tigges S, Bleich S, Neund&#xf6;rfer B, Kornhuber J, Hecht MJ. Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(4):245&#x2013;249. doi: 10.1080/14660820410021294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820410021294</ArticleId><ArticleId IdType="pubmed">15799555</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragg JJ, Seals R, Cashman N, Weisskopf MG. Journal club: depression before and after diagnosis with amyotrophic lateral sclerosis. Neurology. 2016;87(21):e257&#x2013;e259. doi: 10.1212/WNL.0000000000003363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003363</ArticleId><ArticleId IdType="pmc">PMC5123558</ArticleId><ArticleId IdType="pubmed">27872230</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner S, Kollewe K, Abdulla S, Zapf A, Dengler R, Petri S. Interaction of physical function, quality of life and depression in amyotrophic lateral sclerosis: characterization of a large patient cohort. BMC Neurol. 2015;15:84. doi: 10.1186/s12883-015-0340-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-015-0340-2</ArticleId><ArticleId IdType="pmc">PMC4493831</ArticleId><ArticleId IdType="pubmed">25982050</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabkin JG, Goetz R, Factor-Litvak P, Hupf J, McElhiney M, Singleton J, Mitsumoto H. Depression and wish to die in a multicenter cohort of ALS patients. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(3&#x2013;4):265&#x2013;273. doi: 10.3109/21678421.2014.980428.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.980428</ArticleId><ArticleId IdType="pmc">PMC4441849</ArticleId><ArticleId IdType="pubmed">25482273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Zickler C, H&#xe4;cker S, Bruno MA, Demertzi A, Pellas F, Laureys S, K&#xfc;bler A. Life can be worth living in locked-in syndrome. ProgBrain Res. 2009;177:339&#x2013;351. doi: 10.1016/S0079-6123(09)17723-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0079-6123(09)17723-3</ArticleId><ArticleId IdType="pubmed">19818912</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzma-Kozakiewicz M, Andersen PM, Ciecwierska K, V&#xe1;zquez C, Helczyk O, Loose M, Uttner I, Ludolph AC, Lul&#xe9; D. An observational study on quality of life and preferences to sustain life in locked-in state. Neurology. 2019;93(10):e938&#x2013;e945. doi: 10.1212/WNL.0000000000008064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008064</ArticleId><ArticleId IdType="pmc">PMC6745736</ArticleId><ArticleId IdType="pubmed">31391247</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuz T, Birbaumer N, Hautzinger M, K&#xfc;bler A. Psychosocial adjustment to ALS: a longitudinal study. Front Psychol. 2015;6:1197. doi: 10.3389/fpsyg.2015.01197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2015.01197</ArticleId><ArticleId IdType="pmc">PMC4568392</ArticleId><ArticleId IdType="pubmed">26441696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Pauli S, Altintas E, Singer U, Merk T, Uttner I, Birbaumer N, Ludolph AC. Emotional adjustment in amyotrophic lateral sclerosis (ALS) J Neurol. 2012;259(2):334&#x2013;341. doi: 10.1007/s00415-011-6191-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6191-x</ArticleId><ArticleId IdType="pubmed">21808983</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Nonnenmacher S, Sorg S, Heimrath J, Hautzinger M, Meyer TD, K&#xfc;bler A, Birbaumer N, Ludolph AC. Live and let die: existential decision processes in a fatal disease. J Neurol. 2014;261(3):518&#x2013;525. doi: 10.1007/s00415-013-7229-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7229-z</ArticleId><ArticleId IdType="pubmed">24413639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, Shefner J. A revision of the El Escorial criteria: 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5&#x2013;6):291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, Hortob&#xe1;Gyi T, Rosenfeld J, Silani V, Ince PG, Turner MR. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3&#x2013;4):153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1&#x2013;2):13&#x2013;21. doi: 10.1016/s0022-510x(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci. 2008;275(1&#x2013;2):69&#x2013;73. doi: 10.1016/j.jns.2008.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.07.016</ArticleId><ArticleId IdType="pubmed">18721928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammer EM, H&#xe4;cker S, Hautzinger M, Meyer TD, K&#xfc;bler A. Validity of the ALS-Depression-Inventory (ADI-12)&#x2013;a new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. J Affect Disord. 2008;109(1&#x2013;2):213&#x2013;219. doi: 10.1016/j.jad.2007.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2007.11.012</ArticleId><ArticleId IdType="pubmed">18262283</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernheim JL, Buyse M. The Anamnestic Comparative Self-Assessment for Measuring the Subjective Quality of Life of Cancer Patients. J Psychosoc Oncol. 1993;1(4):25&#x2013;38. doi: 10.1300/J077v01n04_03.</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J077v01n04_03</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickey AM, Bury G, O&#x2019;Boyle CA, Bradley F, O'Kelly FD, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ. 1996;313(7048):29&#x2013;33. doi: 10.1136/bmj.313.7048.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.313.7048.29</ArticleId><ArticleId IdType="pmc">PMC2351443</ArticleId><ArticleId IdType="pubmed">8664768</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Kuzma-Kozakiewicz M, Keller J, Aho-&#xd6;zhan HEA, Ciecwierska K, Szejko N, V&#xe1;zquez C, B&#xf6;hm S, Badura-Lotter G, Meyer TD, Petri S, Linse K, Hermann A, Semb O, Stenberg E, Nackberg S, Dorst J, Uttner I, H&#xe4;ggstr&#xf6;m A-C, Ludolph AC, Lul&#xe9; D. Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications. J Neurol. 2018;265(7):1600&#x2013;1606. doi: 10.1007/s00415-018-8861-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8861-4</ArticleId><ArticleId IdType="pubmed">29728768</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod JE, Clarke DM. A review of psychosocial aspects of motor neurone disease. J Neurol Sci. 2007;258(1&#x2013;2):4&#x2013;10. doi: 10.1016/j.jns.2007.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.03.001</ArticleId><ArticleId IdType="pubmed">17445834</ArticleId></ArticleIdList></Reference><Reference><Citation>Caga J, Ramsey E, Hogden A, Mioshi E, Kiernan MC. A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Palliat Support Care. 2015;13(4):1019&#x2013;1024. doi: 10.1017/S1478951514000881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1478951514000881</ArticleId><ArticleId IdType="pubmed">25137152</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor L, Wicks P, Leigh PN, Goldstein LH. Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders. Eur J Neurol. 2010;17(8):1047&#x2013;1053. doi: 10.1111/j.1468-1331.2010.02960.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2010.02960.x</ArticleId><ArticleId IdType="pubmed">20158515</ArticleId></ArticleIdList></Reference><Reference><Citation>Real RGL, Herbert C, Kotchoubey B, Wessig C, Volkmann J, K&#xfc;bler A. Psychophysiological correlates of coping and quality of life in patients with ALS. Clin Neurophysiol. 2014;125(5):955&#x2013;961. doi: 10.1016/j.clinph.2013.09.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2013.09.040</ArticleId><ArticleId IdType="pubmed">24210996</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsson Larsson B, Ozanne AG, Nordin K, Nygren I. A prospective study of quality of life in amyotrophic lateral sclerosis patients. Acta Neurol Scand. 2017;136(6):631&#x2013;638. doi: 10.1111/ane.12774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12774</ArticleId><ArticleId IdType="pubmed">28523721</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller GA, Galanter E, Pribram KH. Plans and the structure of behavior. New York: Henry Holt and Co; 1960.</Citation></Reference><Reference><Citation>Montel S, Albertini L, Desnuelle C, Spitz E. Evolution of quality of life, mental health, and coping strategies in amyotrophic lateral sclerosis: a pilot study. J Palliat Med. 2012;15(11):1181&#x2013;1184. doi: 10.1089/jpm.2012.0162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2012.0162</ArticleId><ArticleId IdType="pubmed">23039217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, H&#xe4;cker S, Ludolph AC, Birbaumer N, K&#xfc;bler A. Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int. 2008;105(23):397&#x2013;403. doi: 10.3238/arztebl.2008.0397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2008.0397</ArticleId><ArticleId IdType="pmc">PMC2696844</ArticleId><ArticleId IdType="pubmed">19626161</ArticleId></ArticleIdList></Reference><Reference><Citation>Grehl T, Rupp M, Budde P, Tegenthoff M, Fangerau H. Depression and QOL in patients with ALS: how do self-ratings and ratings by relatives differ? Qual Life Res. 2011;20(4):569&#x2013;574. doi: 10.1007/s11136-010-9781-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-010-9781-7</ArticleId><ArticleId IdType="pubmed">21086185</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore NJ, Pioro EP. Depression in ALS in a large self-reporting cohort. Neurology. 2016;86(11):1031&#x2013;1038. doi: 10.1212/WNL.0000000000002465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002465</ArticleId><ArticleId IdType="pubmed">26888995</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat P-F, Silani V, Tomik B, Wasner M, Weber M. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke S, Hickey AM, O'Boyle CA, Hardiman O. Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res. 2001;10(2):149&#x2013;158. doi: 10.1023/a:1016704906100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1016704906100</ArticleId><ArticleId IdType="pubmed">11642685</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuz T, Birbaumer N, Hautzinger M, K&#xfc;bler A. Coping with amyotrophic lateral sclerosis: an integrative view. J Neurol Neurosurg Psychiatry. 2010;81(8):893&#x2013;898. doi: 10.1136/jnnp.2009.201285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.201285</ArticleId><ArticleId IdType="pubmed">20587497</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordeson A, Engstr&#xf6;m B, Norberg A. Self-reported quality of life for patients with progressive neurological diseases. Qual Life Res. 1998;7(3):257&#x2013;266. doi: 10.1023/a:1024950417332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1024950417332</ArticleId><ArticleId IdType="pubmed">9584556</ArticleId></ArticleIdList></Reference><Reference><Citation>Neudert C, Wasner M, Borasio GD. Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;191(1&#x2013;2):103&#x2013;109. doi: 10.1016/s0022-510x(01)00612-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(01)00612-8</ArticleId><ArticleId IdType="pubmed">11676999</ArticleId></ArticleIdList></Reference><Reference><Citation>Neudert C, Wasner M, Borasio GD. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliat Med. 2004;7(4):551&#x2013;557. doi: 10.1089/jpm.2004.7.551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2004.7.551</ArticleId><ArticleId IdType="pubmed">15353099</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin M, Gaffney R, Corr B, Mays I, Hardiman O. From first symptoms to diagnosis of amyotrophic lateral sclerosis: perspectives of an Irish informal caregiver cohort-a thematic analysis. BMJ Open. 2017;7(3):e014985. doi: 10.1136/bmjopen-2016-014985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-014985</ArticleId><ArticleId IdType="pmc">PMC5372020</ArticleId><ArticleId IdType="pubmed">28320799</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T, Hardiman O, Pinto-Grau M, Lonergan K, Heverin M, Tobin K, Staines A, Galvin M, Pender N. Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads. J Neurol. 2018;265(4):793&#x2013;808. doi: 10.1007/s00415-018-8770-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8770-6</ArticleId><ArticleId IdType="pubmed">29396678</ArticleId></ArticleIdList></Reference><Reference><Citation>Linse K, R&#xfc;ger W, Joos M, Schmitz-Peiffer H, Storch A, Hermann A. Eye-tracking-based assessment suggests preserved well-being in locked-in patients. Ann Neurol. 2017;81(2):310&#x2013;315. doi: 10.1002/ana.24871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24871</ArticleId><ArticleId IdType="pubmed">28074605</ArticleId></ArticleIdList></Reference><Reference><Citation>Aho-&#xd6;zhan HEA, B&#xf6;hm S, Keller J, Dorst J, Uttner I, Ludolph AC, Lul&#xe9; D. Experience matters: neurologists&#x2019; perspectives on ALS patients&#x2019; well-being. J Neurol. 2017;264(4):639&#x2013;646. doi: 10.1007/s00415-016-8382-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8382-y</ArticleId><ArticleId IdType="pubmed">28120043</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>